COMMUNIQUÉS West-GlobeNewswire

Interpace Diagnostics Announces Expansion of LabCorp National Agreement
20/03/2018
PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
20/03/2018
PLYMOUTH MEETING, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced it has closed an agreement providing ApolloBio Corp. (NEEQ:430187) with the exclusive right to [...]
Dermira to Present at 17th Annual Needham Healthcare Conference
20/03/2018
MENLO PARK, Calif., March 20, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]
12th Annual National Walk for Epilepsy Highlights Importance of Building Education, Raising Awareness and Funding Research for 3.4 Million Americans Living with Seizures
20/03/2018
LANDOVER, Md., March 20, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation’s 12 th Annual National Walk for Epilepsy will be held on April 14 th on the National Mall in Washington, D.C.. The event unites families from [...]
Ogilvy CommonHealth Worldwide’s Cullmann and Campano take the stage at ePharma
20/03/2018
PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP) ( www.wpp.com ), today announced Chris Cullmann, head of digital [...]
Iridex Receives CE Mark for Transilluminated Probe
20/03/2018
MOUNTAIN VIEW, Calif., March 20, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) is pleased to announce the availability of the G-Probe Illuminate™ device in Europe. The probe, now with CE mark, offers [...]
Business and Medical Leaders Join BioSig Advisory Board
20/03/2018
Santa Monica, CA, March 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Aeglea BioTherapeutics to Present at 17th Annual Needham Healthcare Conference
20/03/2018
AUSTIN, Texas, March 20, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Incysus to Present Scientific Overview at the 2018 CAR-T Congress USA Meeting
20/03/2018
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today announced the [...]
Women In Bio Announces Appointment of Mary Thistle to the Board of Homology Medicines
20/03/2018
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, is pleased to announce [...]
Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
20/03/2018
NEW HAVEN, Conn., March 20, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it has successfully incorporated the use of High Resolution Melt (HRM) technology into [...]
Affimed Reports Financial Results for Fourth Quarter and Year End 2017
20/03/2018
Heidelberg, Germany, March 20, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial [...]
Repligen Announces Market Launch of OPUS® 80R, Reinforces Technology Leadership in Pre-Packed Chromatography
20/03/2018
- First and only available 80 cm diameter pre-packed column to address large-scale clinical and commercial-scale manufacturing of biological drugs - WALTHAM, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- Repligen [...]
Cutera to Present at the Sidoti Spring 2018 Investor Conference
20/03/2018
BRISBANE, Calif., March 20, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, [...]
SIGA Technologies Announces Relisting on Nasdaq
20/03/2018
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs [...]
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolescents With ADHD
20/03/2018
Results Suggest that Data from Single Classroom-style Efficacy Study May Be Applicable Across Pediatric, Adolescent and Adult ADHD Patient Populations CORALVILLE, Iowa, March 20, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc [...]
New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active
20/03/2018
Positive Data on Exclusive AdaptivCRT(TM) Feature Unveiled at EHRA Scientific Sessions 2018 DUBLIN and BARCELONA, Spain - March 20 , 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) [...]
Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine
20/03/2018
WAYNE, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Merus and the Vall d’Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer
20/03/2018
UTRECHT, The Netherlands, March 20, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), and the Vall d’ [...]

Pages